<DOC>
	<DOCNO>NCT00355459</DOCNO>
	<brief_summary>The purpose research project determine effect oral tetracycline Minocycline ( Minocin ) tear film composition tear lipid ( meibomian gland secretion ) characteristic patient chronic Blepharitis associate dry eye .</brief_summary>
	<brief_title>A Prospective Clinical Study Assessing Effects Tetracycline Antibiotic Tear Film Tear Lipid Composition Within Population Patients Diagnosed With Blepharitis Dry Eye Disease</brief_title>
	<detailed_description>Tear film dysfunction , collectively diagnose dry eye syndrome Meibomian Gland Dystrophy ( MGD ) afflict million individual worldwide , 10 million United States alone . Typically , symptom include ocular burning , foreign body sensation , photophobia , redness symptom result overall chronic discomfort patient . Tetracycline analogue , minocycline , demonstrate effectiveness treat primary meibomianitis , one type chronic blepharitis prescribe patient sometime . It demonstrate tetracycline inhibit lipase activity therefore decrease release noxious free fatty acid . Tetracycline also inhibit bacterial lipase activity vitro effect . We investigate association chronic blepharitis eyelid meibomian gland lipid microflora number year discover important relationship lipid chronic blepharitis disease state . Because high concentration 12 hour post dose , low renal clearance , long half life , high level bind serum protein , minocycline suggest good treatment option . The study propose determine effect oral treatment tetracycline analogue Tear Film Tear Lipid Composition within Population Patients Diagnosed Dry Eye Disease Meibomian Gland Dysfunction . Patients diagnose dry eye syndrome well Meibomian Gland Dystrophy ( MGD ) select participate clinical study : baseline visit , 1-month follow initiation treatment , 3-months initiation treatment , 3-months discontinuation treatment . Once assessed qualified take part trial , participant undergo follow test visit : I. Ocular assessment sign symptom II . Evaporometry III . Fluorophotometery IV . Schirmers Testing V. TBUT VI . Bacteriology VII . Transillumination &amp; Meibography VIII . Meibomian gland expression lipid analysis After completion baseline visit , patient give 2-week regimen 50-mg dose Minocycline follow 10-week supply 100-mg Minocycline take daily breakfast . In addition , continue use artificial tear additional treatment prescribe treat physician . I. Ocular assessment Patients ' symptomology well assessor ' diagnostic finding record review detail patient entrance study . These include visual acuity , biomicroscopy lids/lashes , conjunctiva , cornea . Moreover , corneal well conjunctival stain perform use two colored dye : Lissamine green fluorescein . In addition , investigator record pathology patient ' natural lens , iris , pupil . II . Evaporometer : Evaporative flow contribution turnover An evaporometer utilizes pump direct air dry tube ( Hammond Drierite , Xenia , OH ) goggle . The goggle contain water vapor detector temperature monitor place firmly eye . The pumped air pass goggle , reduce humidity 15 % , time pump turn . The increase humidity due evaporation skin evaporate tear measure stored computer . The process carry first eyelid close open ; difference tear evaporation rate . The area interpalpebral ocular surface use calculate evaporation per unit area ; image area capture use digital camera calculate directly aid computer software ( ADOBE Photoshop , version 6.0.1.2001 , ADOBE Systems , San Jose , California ) . Evaporative outflow percentage available tear volume calculate rate rise relative humidity inside goggle eye open minus evaporative contribution close eye skin within goggle . The evaporative contribution turnover calculate evaporative outflow per available tear volume per minute divide tear turnover . III . Fluorophotometer : Tear volume , flow turnover Background fluorescence determine prior instillation 0.5 micro liter 0.5 % sodium fluorescein onto ocular surface . Utilizing fluorophotometer ( Fluorotron Master , Ocumetrics , Mountain View , CA ) , eight measurement take eye determine tear fluorescence . The first two measurement perform one minute apart subsequent measurement repeat three minute interval completion 19 minute . This data analyze calculate tear volume , flow tear turnover . IV . Schirmers test : Quantitative tear measurement perform without anesthetic Drops . A commonly use paper wick place eyeball out third low lid cul-de-sac order measure quantitatively production tear . This test typically take 5 minute perform . V. Tear Break-Up Time - Quantitative/Qualitative assessment corneal conjunctival dry spot ( devitalized surface epithelial cell ) A drop fluorescein instill eye patient . Patient ask blink normally dye spread evenly eye . Once complete , patient ask blink hold eye open assessor use stop watch record number second take tear film break-up . This tool allow examiner grade quality tear film . Normal control patient TBUT 10-12 second dry eye patient TBUT le 2 second . VI . Bacteriology - Eyelid microflora evaluation Samples eyelid conjunctival microflora eye take separately calcium alginate swab dip 0.9 % salt solution . After streak swab different plate ( blood agar , chocolate agar , reduce brucella blood agar ) , place tube thioglycolate bacteriological assessment . VII . Transillumination &amp; Meibography - Quantitative assessment lower lid meibomian gland lipid production An excretory gland , primary role meibomian glands produce secrete lipid tear film . The purpose test determine quantitatively number lower lid gland functional lipid producer . A transilluminator ( muscle light ) light disperse tip use illuminate gland . The small band light transilluminate invert low lid patient . With use digital camera , picture take order ass vital gland drop-outs ( non-producing gland ) . This accomplished frame grabber match Hitachi KP-F2A progressive scanner infrared camera mount slit lamp microscope . Images capture store use image software . VIII . Meibomian gland expression lipid analysis - Lower Upper eye lid sample collect assayed biochemical makeup With use ocular conformer cotton tip applicator , sample upper low lid meibomian gland lipid collect assessed make-up</detailed_description>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Blepharitis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<mesh_term>Tetracycline</mesh_term>
	<criteria>Patients 18 year age , patient willing able comply protocol . Insidious onset great three month 's duration ocular symptom consistent dry eye meibomian gland disease . Ocular surface vital stain consistent aqueous deficient dry eye less +1 conjunctival injection minimal lid inflammation . Normal control also test trial . Any patient punctual occlusion punctual plug within past 2 month . Patients active ocular infection inflammatory disease , history herpetic keratitis , history retinal detachment , concurrent contact lens use trial period , ocular surgery within past six month , patient glaucoma , anterior membrane dystrophy , active trichiasis eyelid globe malposition abnormality , e.g. , entropion , ectropion , etc . Patients epiphora ( excessive tearing ) . Moreover , patient take medication know effect aqueous tear production meibomian secretion use tetracycline tetracycline analog treatment medical condition within past 3 month . Patient must participate ( currently participate ) investigational therapeutic drug device trial within previous 30 day prior start date trial . In addition , patient suffer organic brain syndrome major psychiatric disorder would interfere compliance subjective reporting discourage participate trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>88 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Meibomian Gland Dystrophy</keyword>
</DOC>